Pseudomonas oryzihabitans | |
---|---|
Scientific classification | |
Domain: | Bacteria |
Phylum: | Pseudomonadota |
Class: | Gammaproteobacteria |
Order: | Pseudomonadales |
Family: | Pseudomonadaceae |
Genus: | Pseudomonas |
Species: | P. oryzihabitans |
Binomial name | |
Pseudomonas oryzihabitans Kodoma, et al., 1985 | |
Type strain | |
ATCC 43272 CCUG 12540 Contents | |
Synonyms | |
|
Pseudomonas oryzihabitans is a nonfermenting yellow-pigmented, gram-negative, rod-shaped bacterium that can cause sepsis, peritonitis, endophthalmitis, and bacteremia. [1] It is an opportunistic pathogen of humans and warm-blooded animals that is commonly found in several environmental sources, from soil to rice paddies. They can be distinguished from other nonfermenters by their negative oxidase reaction and aerobic character. [1] This organism can infect individuals that have major illnesses, including those undergoing surgery or with catheters in their body. [2] Based on the 16S RNA analysis, these bacteria have been placed in the Pseudomonas putida group. [3]
Part of the genus Pseudomonas , originally described in 1894, these bacteria were first identified in urine and gastrointestinal specimens in 1928 by two scientists, E.G. Dresel and O Stickl. [4] At first, this organism was named Chromobacterium typhiflavuum because it closely resembled the bacteria that caused enteric fever. [4] The name change to Pseudomonas oryzihabitans occurred in 1985 after scientist Kentaro Kodama and his team isolated the bacteria from a rice field and found that it had a phenotypic similarity to the pseudomonas organisms. [4] This organism has also been isolated in the hospital environment from a wide variety of sites such as wounds, eyes, skin, ears, and several other places, although they can be found in damp environments as well. [5] As of today, there is little known about the pathogenic qualities of P. oryzihabitans, so possible virulent strains cannot be described or identified absolutely.
Pseudomonas oryzihabitans, although an uncommon pathogen, is able to cause infections in individuals that usually have compromised immune systems. While most strains of this bacteria do not cause infections, the patients that acquire P. oryzihabitans most likely have an underlying disease, and it spreads while the patients are hospitalized. [5] This includes patients that have recently undergone surgery and also those affected by diseases such as AIDS, leukemia, and other illnesses that have a detrimental effect on the immune system. [6]
From several studies involving cases of P. oryzihabitans, research reveals that there is a close relationship between infection, underlying disease, and the presence of catheters in patients. [2] This means that infections occur most in people that have debilitating disease and have artificial material located in their bodies. Along with catheters, P. oryzihabitans are most commonly found at sites involved with respiratory equipment and devices for continuous ambulatory dialysis, and these bacteria can spread through contaminated fluids and unsterilized or defiled medical tools. [2] If this is the case, it is important for hygiene to be maintained internally and externally to help stop the spread of the bacteria and prevent infectious disease. Infections can be either nosocomially acquired, which means that the bacteria originated during a patient's duration in the hospital forty-eight hours after admittance, or they are community-acquired, which means that the patient had evidence of infection before admission or during the first forty-eight hours in the hospital. [5]
Most infections result in bacteraemia in patients that are extremely sick or peritonitis in individuals that undergo ambulatory peritoneal dialysis consistently. [2] Several reports of infections these bacteria cause are correlated with patients who have AIDS. [6] P. oryzihabitans is increasingly identified as a cause of opportunistic infections, taking advantage of weak immune systems in people. However, it is rare for the infection to escalate into sepsis, but there have been cases where patients have acquired the disease. Although these bacteria are able to cause infections, its role as a pathogen is questionable since this does not happen very often.[ citation needed ]
Symptoms of an infection of P. oryzihabitans are actually quite vague and similar to the signs that can indicate other illnesses or diseases, so it is relatively difficult to identify when only looking at symptoms. However, in several cases, these infections result after an individual's immune system has been weakened, so it is likely to occur in recovering or ill patients. Most patients, after receiving treatment for another disease or during recovery from surgery, experience chills and increase in body temperature. [2] While these symptoms could mean a variety of things, it is clear that the patient's recovery is halted and that there is an infection of some sort. In an example where a woman developed an infection of P. oryzihabitans from a case of sinusitis, she experienced the same chills and elevated temperature, but also nasal discharge containing pus, right facial pain, and a fever. [2]
To establish that these patients are infected with Pseudomonas oryzihabitans, blood samples are collected for tests and sent for cultures to be identified. Since the presence of these bacteria may not initially be known by any symptoms, having it identified in a lab will help with treating it. In certain situations, its role as a pathogen is also identified through evidence of pulmonary signs and symptoms, radiograph findings, and positive blood cultures. [5]
In the past reported cases of P. oryzihabitans, the patients were given antibiotics to treat the infection. These bacteria are fairly easy to treat, with a range of antibiotics that they are susceptible to. The antibiotics that the infectious disease responded to are gentamicin, ciprofloxacin, carbapenems, cephalosprins, aminoglycosides, and quinolones. [2] While there are several kinds of medicines that can treat P. oryzihabitans, the carbapenem displayed the best results against infections. In a study where cultures of these bacteria were grown, tests showed that all the isolates were susceptible to carbapenem antibiotics, however, the vulnerability to other medicines differed among the groups. [5] Past studies also revealed that P. oryzihabitans were susceptible in vitro to antipseudomonal penicillins. [4] Treatments for the bacteria differ and depend on the host and the different strains of P. oryzihabitans.[ citation needed ]
The types of antibiotics that P. oryzihabitans are resistant to ampicillin, amoxicillin-clavulanic acid, and cefazolin. [7] Since these bacteria are not as harmful or virulent to the host, antibiotics should clear up the infection, although in some cases, since they can be found around the sites of prosthetic material, catheter removal is required. [8]
In order to prevent an infection from these bacteria, good hygiene is required, especially when foreign materials or objects like catheters are in the body. However, even this cannot completely prevent P. oryzihabitans because of environmental contamination that could lead to acquirement of this organism. [6]
In cases of patients with indwelling catheters, special care should be taken so that a community-acquired infection does not occur. It is recommended that these people should avoid the use of bath sponges and wet items for skin care, as these can be sites of growth and contamination of the bacteria. [6]
By studying the environments in which P. oryzihabitans are found, scientists are able to get a clearer picture on how infections occur and how these bacteria may be found on individuals outside hospitals. Although the bacteria can be nosocomially acquired, the environment must be taken into account as a host for them. These bacteria, while observed in hospital sites, can originally be found in damp environments such as locations with water, stagnant or running, and soil. Data indicates that environmental sources could be a reason for the development of an infectious disease, as well as the presence of foreign objects in the body. [6]
These bacteria were first studied in depth and identified after they were isolated from a rice paddy. [9]
In one study, researchers found that P. oryzihabitans contaminated drinking water supply and questioned whether or not these bacteria are commonly found in naturally distributed water. [6] The water supply systems were in contact with an object that is directly connected to sinkholes, which are known sites for the bacteria to linger. Since sinkholes are large underground cavities, they have enough room to foster water, making this environment an ideal place for P. oryzihabitans to grow.[ citation needed ]
These bacteria are able to persist in biofilms where they are relatively protected from chlorine disinfection. [10] Their presence in drinking water is attributable to this fact.
When an infection caused by P. oryzihabitans was reported in a patient with AIDS and an indwelling catheter, scientists took samples from the man's home to see where these bacteria were located and to find out a possible explanation for his infection. The patient claimed that he followed the strict hygienic guidelines pertaining to catheters, so an environmental factor is responsible for the infection. They ended up tracing the origin of the bacteria to a bath sponge. In order for researchers to validate these findings, they also tested bath sponges from other households and found P. oryzihabitans in some separate samples as well. [7] This suggests that the water could be contaminated with these bacteria, which in turn, could lead to potential infections in certain individuals.
Infections from P. oryzihabitans are increasingly associated with catheter-related bacteremia, peritonitis, wound infections, and meningitis (after surgery), mostly in patients with diseases that significantly weaken the individual. [7]
Foreign material present in the body predisposes patients to infections, as well as those with severely weakened immune systems. [7]
Most cases are nosocomially acquired, however, there are infections detected upon admission to a hospital. [7] There are also cases where P. oryzihabitans was a causation of sepsis in some people. The only other oxidase negative Pseudomonas is P. luteola .
The cells of Pseudomonas oryzihabitans are rods with rounded ends. These Gram-negative bacteria are able to move due to a flagellum, and the cells occur singularly and very rarely in pairs. Strains of these bacteria produce a yellow water-insoluble pigment in their cells. [9]
Their metabolism is restricted to an aerobic respiratory system. They are oxidative but not fermentative, and when isolated and cultured, their growth occurs on MacConkey agar and SS agar. [9]
Peritonitis is inflammation of the localized or generalized peritoneum, the lining of the inner wall of the abdomen and cover of the abdominal organs. Symptoms may include severe pain, swelling of the abdomen, fever, or weight loss. One part or the entire abdomen may be tender. Complications may include shock and acute respiratory distress syndrome.
Bloodstream infections (BSIs), which include bacteremias when the infections are bacterial and fungemias when the infections are fungal, are infections present in the blood. Blood is normally a sterile environment, so the detection of microbes in the blood is always abnormal. A bloodstream infection is different from sepsis, which is the host response to bacteria.
Klebsiella pneumoniae is a Gram-negative, non-motile, encapsulated, lactose-fermenting, facultative anaerobic, rod-shaped bacterium. It appears as a mucoid lactose fermenter on MacConkey agar.
Acinetobacter is a genus of gram-negative bacteria belonging to the wider class of Gammaproteobacteria. Acinetobacter species are oxidase-negative, exhibit twitching motility, and occur in pairs under magnification.
A hospital-acquired infection, also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility. To emphasize both hospital and nonhospital settings, it is sometimes instead called a healthcare–associated infection. Such an infection can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, diagnostic laboratory or other clinical settings. Infection is spread to the susceptible patient in the clinical setting by various means. Health care staff also spread infection, in addition to contaminated equipment, bed linens, or air droplets. The infection can originate from the outside environment, another infected patient, staff that may be infected, or in some cases, the source of the infection cannot be determined. In some cases the microorganism originates from the patient's own skin microbiota, becoming opportunistic after surgery or other procedures that compromise the protective skin barrier. Though the patient may have contracted the infection from their own skin, the infection is still considered nosocomial since it develops in the health care setting. An easy way to understand the term is that the infection tends to lack evidence that it was incubating, or present when the patient entered the healthcare setting, thus meaning it was acquired post-admission.
Pseudomonas aeruginosa is a common encapsulated, gram-negative, aerobic–facultatively anaerobic, rod-shaped bacterium that can cause disease in plants and animals, including humans. A species of considerable medical importance, P. aeruginosa is a multidrug resistant pathogen recognized for its ubiquity, its intrinsically advanced antibiotic resistance mechanisms, and its association with serious illnesses – hospital-acquired infections such as ventilator-associated pneumonia and various sepsis syndromes.
Carbapenems are a class of very effective antibiotic agents most commonly used for the treatment of severe bacterial infections. This class of antibiotics is usually reserved for known or suspected multidrug-resistant (MDR) bacterial infections. Similar to penicillins and cephalosporins, carbapenems are members of the beta lactam class of antibiotics, which kill bacteria by binding to penicillin-binding proteins, thus inhibiting bacterial cell wall synthesis. However, these agents individually exhibit a broader spectrum of activity compared to most cephalosporins and penicillins. Furthermore, carbapenems are typically unaffected by emerging antibiotic resistance, even to other beta-lactams.
Community-acquired pneumonia (CAP) refers to pneumonia contracted by a person outside of the healthcare system. In contrast, hospital-acquired pneumonia (HAP) is seen in patients who have recently visited a hospital or who live in long-term care facilities. CAP is common, affecting people of all ages, and its symptoms occur as a result of oxygen-absorbing areas of the lung (alveoli) filling with fluid. This inhibits lung function, causing dyspnea, fever, chest pains and cough.
Stenotrophomonas maltophilia is an aerobic, nonfermentative, Gram-negative bacterium. It is an uncommon bacterium and human infection is difficult to treat. Initially classified as Bacterium bookeri, then renamed Pseudomonas maltophilia, S. maltophilia was also grouped in the genus Xanthomonas before eventually becoming the type species of the genus Stenotrophomonas in 1993.
Alcaligenes is a genus of Gram-negative, aerobic, rod-shaped bacteria. The species are motile with amphitrichous flagella and rarely nonmotile. It is a genus of non-fermenting bacteria. Additionally, some strains of Alcaligenes are capable of anaerobic respiration, but they must be in the presence of nitrate or nitrite; otherwise, their metabolism is respiratory and never fermentative; The genus does not use carbohydrates. Strains of Alcaligenes are found mostly in the intestinal tracts of vertebrates, decaying materials, dairy products, water, and soil; they can be isolated from human respiratory and gastrointestinal tracts and wounds in hospitalized patients with compromised immune systems. They are occasionally the cause of opportunistic infections, including nosocomial sepsis.
Elizabethkingia meningoseptica is a Gram-negative, rod-shaped bacterium widely distributed in nature. It may be normally present in fish and frogs; it may be isolated from chronic infectious states, as in the sputum of cystic fibrosis patients. In 1959, American bacteriologist Elizabeth O. King was studying unclassified bacteria associated with pediatric meningitis at the Centers for Disease Control and Prevention in Atlanta, when she isolated an organism that she named Flavobacterium meningosepticum. In 1994, it was reclassified in the genus Chryseobacterium and renamed Chryseobacterium meningosepticum(chryseos = "golden" in Greek, so Chryseobacterium means a golden/yellow rod similar to Flavobacterium). In 2005, a 16S rRNA phylogenetic tree of Chryseobacteria showed that C. meningosepticum along with C. miricola were close to each other but outside the tree of the rest of the Chryseobacteria and were then placed in a new genus Elizabethkingia named after the original discoverer of F. meningosepticum.
Acinetobacter baumannii is a typically short, almost round, rod-shaped (coccobacillus) Gram-negative bacterium. It is named after the bacteriologist Paul Baumann. It can be an opportunistic pathogen in humans, affecting people with compromised immune systems, and is becoming increasingly important as a hospital-derived (nosocomial) infection. While other species of the genus Acinetobacter are often found in soil samples, it is almost exclusively isolated from hospital environments. Although occasionally it has been found in environmental soil and water samples, its natural habitat is still not known.
Mycobacterium fortuitum is a nontuberculous species of the phylum Actinomycetota, belonging to the genus Mycobacterium.
Ralstonia is a genus of bacteria, previously included in the genus Pseudomonas. It is named after the American bacteriologist Ericka Ralston. Ericka Ralston was born Ericka Barrett in 1944 in Saratoga, California, and died in 2015 in Sebastopol, California. While in graduate school at the University of California at Berkeley, she identified 20 strains of Pseudomonas which formed a phenotypical homologous group, and named them Pseudomonas pickettii, after M.J. Pickett in the Department of Bacteriology at the University of California at Los Angeles, from whom she had received the strains. Later, P. pickettii was transferred to the new genus Ralstonia, along with several other species. She continued her research into bacterial pathogenesis under the name of Ericka Barrett while a professor of microbiology at the University of California at Davis from 1977 until her retirement in 1996.
Pseudomonas infection refers to a disease caused by one of the species of the genus Pseudomonas.
Morganella morganii is a species of Gram-negative bacteria. It has a commensal relationship within the intestinal tracts of humans, mammals, and reptiles as normal flora. Although M. morganii has a wide distribution, it is considered an uncommon cause of community-acquired infection, and it is most often encountered in postoperative and other nosocomial infections, such as urinary tract infections.
Corynebacterium amycolatum is a gram-positive, non-spore-forming, aerobic or facultatively anaerobic bacillus capable of fermentation with propionic acid as the major end product of its glucose metabolism. One of its best known relatives is Corynebacterium diphtheriae, the causative agent of diphtheria. C. amycolatum is a common component of the natural flora found on human skin and mucous membranes, and therefore is an occasional contaminant in human blood cultures but can rarely cause infections such as endocarditis.
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are Gram-negative bacteria that are resistant to the carbapenem class of antibiotics, considered the drugs of last resort for such infections. They are resistant because they produce an enzyme called a carbapenemase that disables the drug molecule. The resistance can vary from moderate to severe. Enterobacteriaceae are common commensals and infectious agents. Experts fear CRE as the new "superbug". The bacteria can kill up to half of patients who get bloodstream infections. Tom Frieden, former head of the Centers for Disease Control and Prevention has referred to CRE as "nightmare bacteria". Examples of enzymes found in certain types of CRE are KPC and NDM. KPC and NDM are enzymes that break down carbapenems and make them ineffective. Both of these enzymes, as well as the enzyme VIM have also been reported in Pseudomonas.
ESKAPE is an acronym comprising the scientific names of six highly virulent and antibiotic resistant bacterial pathogens including: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. This group of Gram-positive and Gram-negative bacteria can evade or 'escape' commonly used antibiotics due to their increasing multi-drug resistance (MDR). As a result, throughout the world, they are the major cause of life-threatening nosocomial or hospital-acquired infections in immunocompromised and critically ill patients who are most at risk. P. aeruginosa and S. aureus are some of the most ubiquitous pathogens in biofilms found in healthcare. P. aeruginosa is a Gram-negative, rod-shaped bacterium, commonly found in the gut flora, soil, and water that can be spread directly or indirectly to patients in healthcare settings. The pathogen can also be spread in other locations through contamination, including surfaces, equipment, and hands. The opportunistic pathogen can cause hospitalized patients to have infections in the lungs, blood, urinary tract, and in other body regions after surgery. S. aureus is a Gram-positive, cocci-shaped bacterium, residing in the environment and on the skin and nose of many healthy individuals. The bacterium can cause skin and bone infections, pneumonia, and other types of potentially serious infections if it enters the body. S. aureus has also gained resistance to many antibiotic treatments, making healing difficult. Because of natural and unnatural selective pressures and factors, antibiotic resistance in bacteria usually emerges through genetic mutation or acquires antibiotic-resistant genes (ARGs) through horizontal gene transfer - a genetic exchange process by which antibiotic resistance can spread.
Cefiderocol, sold under the brand name Fetroja among others, is an antibiotic used to treat complicated urinary tract infections when no other options are available. It is indicated for the treatment of multi-drug-resistant Gram-negative bacteria including Pseudomonas aeruginosa. It is given by injection into a vein.